196 related articles for article (PubMed ID: 25517855)
1. Deletion of exon 1 of the SLC16A2 gene: a common occurrence in patients with Allan-Herndon-Dudley syndrome.
García-de Teresa B; González-Del Angel A; Reyna-Fabián ME; Ruiz-Reyes Mde L; Calzada-León R; Pérez-Enríquez B; Alcántara-Ortigoza MA
Thyroid; 2015 Mar; 25(3):361-7. PubMed ID: 25517855
[TBL] [Abstract][Full Text] [Related]
2. Allan-Herndon-Dudley syndrome (AHDS) caused by a novel SLC16A2 gene mutation showing severe neurologic features and unexpectedly low TRH-stimulated serum TSH.
Boccone L; Mariotti S; Dessì V; Pruna D; Meloni A; Loudianos G
Eur J Med Genet; 2010; 53(6):392-5. PubMed ID: 20713192
[TBL] [Abstract][Full Text] [Related]
3. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment.
Zung A; Visser TJ; Uitterlinden AG; Rivadeneira F; Friesema EC
Eur J Endocrinol; 2011 Nov; 165(5):823-30. PubMed ID: 21896621
[TBL] [Abstract][Full Text] [Related]
4. Allan-Herndon-Dudley syndrome (AHDS) in two consecutive generations caused by a missense MCT8 gene mutation. Phenotypic variability with the presence of normal serum T3 levels.
Boccone L; Dessì V; Meloni A; Loudianos G
Eur J Med Genet; 2013 Apr; 56(4):207-10. PubMed ID: 23419639
[TBL] [Abstract][Full Text] [Related]
5. Variable Clinical Characteristics and Molecular Spectrum of Patients with Syndromes of Reduced Sensitivity to Thyroid Hormone: Genetic Defects in the THRB and SLC16A2 Genes.
Choi JH; Cho JH; Kim JH; Yoo EG; Kim GH; Yoo HW
Horm Res Paediatr; 2018; 90(5):283-290. PubMed ID: 30497070
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
Novara F; Groeneweg S; Freri E; Estienne M; Reho P; Matricardi S; Castellotti B; Visser WE; Zuffardi O; Visser TJ
Hum Mutat; 2017 Mar; 38(3):260-264. PubMed ID: 27805744
[TBL] [Abstract][Full Text] [Related]
7. Psychomotor retardation caused by a defective thyroid hormone transporter: report of two families with different MCT8 mutations.
Anık A; Kersseboom S; Demir K; Catlı G; Yiş U; Böber E; van Mullem A; van Herebeek RE; Hız S; Abacı A; Visser TJ
Horm Res Paediatr; 2014; 82(4):261-71. PubMed ID: 25247785
[TBL] [Abstract][Full Text] [Related]
8. [A family with Allan-Herndon-Dudley syndrome due to SLC16A2 gene mutation].
Tang YL; Peng J; Xiong J; Pang N; Wu LW; Yang HY; Kessi M; Yin F
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):829-834. PubMed ID: 30392207
[No Abstract] [Full Text] [Related]
9. A novel variant in SLC16A2 associated with typical Allan-Herndon-Dudley syndrome: a case report.
Chen X; Liu L; Zeng C
BMC Pediatr; 2022 Apr; 22(1):180. PubMed ID: 35382784
[TBL] [Abstract][Full Text] [Related]
10. Brain Gene Expression in Systemic Hypothyroidism and Mouse Models of MCT8 Deficiency: The Mct8-Oatp1c1-Dio2 Triad.
Morte B; Gil-Ibañez P; Heuer H; Bernal J
Thyroid; 2021 Jun; 31(6):985-993. PubMed ID: 33307956
[No Abstract] [Full Text] [Related]
11. [The importance of thyroid hormone transporters].
Braun D
Nuklearmedizin; 2015; 54(3):77-81. PubMed ID: 26105714
[TBL] [Abstract][Full Text] [Related]
12. Myelination Delay and Allan-Herndon-Dudley Syndrome Caused by a Novel Mutation in the SLC16A2 Gene.
La Piana R; Vanasse M; Brais B; Bernard G
J Child Neurol; 2015 Sep; 30(10):1371-4. PubMed ID: 25380603
[TBL] [Abstract][Full Text] [Related]
13. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
[TBL] [Abstract][Full Text] [Related]
14. First female with Allan-Herndon-Dudley syndrome and partial deletion of X-inactivation center.
Quesada-Espinosa JF; Garzón-Lorenzo L; Lezana-Rosales JM; Gómez-Rodríguez MJ; Sánchez-Calvin MT; Palma-Milla C; Gómez-Manjón I; Hidalgo-Mayoral I; Pérez de la Fuente R; Arteche-López A; Álvarez-Mora MI; Camacho-Salas A; Cruz-Rojo J; Lázaro-Rodríguez I; Morales-Conejo M; Nuñez-Enamorado N; Bustamante-Aragones A; Simón de Las Heras R; Gomez-Cano MA; Ramos-Gómez P; Sierra-Tomillo O; Juárez-Rufián A; Gallego-Merlo J; Rausell-Sánchez L; Moreno-García M; Sánchez Del Pozo J
Neurogenetics; 2021 Oct; 22(4):343-346. PubMed ID: 34296368
[TBL] [Abstract][Full Text] [Related]
15. Clinical and endocrine features of two Allan-Herndon-Dudley syndrome patients with monocarboxylate transporter 8 mutations.
Kim JH; Kim YM; Yum MS; Choi JH; Lee BH; Kim GH; Yoo HW
Horm Res Paediatr; 2015; 83(4):288-92. PubMed ID: 25896225
[TBL] [Abstract][Full Text] [Related]
16. Elevated TSH levels in a mentally retarded boy.
Crushell E; Reardon W
Eur J Pediatr; 2010 May; 169(5):573-5. PubMed ID: 19936787
[TBL] [Abstract][Full Text] [Related]
17. Expanding the phenotypic spectrum of Allan-Herndon-Dudley syndrome in patients with SLC16A2 mutations.
Remerand G; Boespflug-Tanguy O; Tonduti D; Touraine R; Rodriguez D; Curie A; Perreton N; Des Portes V; Sarret C;
Dev Med Child Neurol; 2019 Dec; 61(12):1439-1447. PubMed ID: 31410843
[TBL] [Abstract][Full Text] [Related]
18. [Exome sequencing revealed Allan-Herndon-Dudley syndrome underlying multiple disabilities].
Arvio M; Philips AK; Ahvenainen M; Somer M; Kalscheuer V; Järvelä I
Duodecim; 2014; 130(21):2202-5. PubMed ID: 25582014
[TBL] [Abstract][Full Text] [Related]
19. Delayed myelination is not a constant feature of Allan-Herndon-Dudley syndrome: report of a new case and review of the literature.
Azzolini S; Nosadini M; Balzarin M; Sartori S; Suppiej A; Mardari R; Greggio NA; Toldo I
Brain Dev; 2014 Sep; 36(8):716-20. PubMed ID: 24268987
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency.
Masnada S; Groenweg S; Saletti V; Chiapparini L; Castellotti B; Salsano E; Visser WE; Tonduti D
Metab Brain Dis; 2019 Dec; 34(6):1565-1575. PubMed ID: 31332729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
